A novel clinical observation in neuroleptic malignant-like syndrome first demonstration of early progression of hydrocephalus
View/ Open
Access
info:eu-repo/semantics/closedAccessDate
2015Author
Kazdal, HızırKanat, Ayhan
Şen, Ahmet
Kırbaş, Serkan
Ardıç, Gizem
Tüfekçi, Ahmet
Ersöz, Tahir
Metadata
Show full item recordCitation
Kazdal, H., Kanat, A., Sen, A., Kirbas, S., Ardic, G., Tufekci, A., & Ersoz, T. (2015). A novel clinical observation in neuroleptic malignant-like syndrome: first demonstration of early progression of hydrocephalus. Journal of clinical psychopharmacology, 35(2), 211–212. https://doi.org/10.1097/JCP.0000000000000293Abstract
o the Editors:
Neuroleptic malignant syndrome (NMS) is a drug-related disease associated with neuroleptics. Many case reports with NMS were published on various neuroleptic drugs1–6; however, the pathogenesis of NMS is well known. It is characterized by fever, severe muscle rigidity, and autonomic and mental status changes.